Therefore, we believe that the mechanism ofTRAIL resistance induction during the activation of inflammation inmacrophage-like AML cells may consist of a IL-1β- associated, throughNF-kB, increase in the expression of the inhibitor of apoptosis cIAP2. The gene discussed is IL1B; the disease is acute myeloid leukemia.